Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134162) titled 'Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes' on Oct. 11.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
Glioma
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2023-05-01
Target Sample Size: Observation group:1283;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=293805
Disclaimer: Curated by HT Syndication....